
Abbott Laboratories (ABT) Q3 comparable sales growth?

Oct 21, 2026
$2.61K Vol.

End date: Oct 21, 2026
Outcomes

<4%
$265.57 Vol.
20%
20%

4% to 6%
$483.67 Vol.
24%
24%

6% to 8%
$783.22 Vol.
50%
50%

8% to 10%
$205.57 Vol.
<1%
<1%

10%+
$871.95 Vol.
15%
15%
Rules
This market will resolve according to Abbott Laboratories' comparable sales growth (year-over-year) for the upcoming third fiscal quarter, as reported in its official company earnings materials.
Comments
Comments